CNVS insider sale of 152,561 shares; 121,792 RSUs vesting to 2028
Rhea-AI Filing Summary
Insider transaction summary for Cineverse Corp. (CNVS): The reporting officer, Mark Antonio Huidor, reported a disposal and several derivative/award holdings. On 10/08/2025 he disposed of 152,561 shares of Class A common stock. Following that transaction his direct holdings include vested and unvested equity awards: a $5.8 strike stock appreciation right exercisable into 50,000 shares, and multiple restricted stock units (RSUs) and other awards totaling 382,746 Class A shares equivalent (sum of listed amounts). A newly acquired grant of 121,792 RSUs was recorded with $0 per-share price and vesting scheduled across 2026–2028. The filing shows staged vesting dates for existing awards.
Positive
- Staged vesting across multiple awards (2026–2028) aligns executive pay with multi-year performance
- Large RSU grant of 121,792 units is structured with clear vesting dates, providing retention incentive
Negative
- Immediate disposal of 152,561 Class A shares on 10/08/2025 reduced direct shareholding
- Aggregate outstanding equity awards (RSUs and SARs convertible to Class A shares) create potential dilution through 2028
Insights
Officer disposed of shares while holding large scheduled equity awards.
The reporting person, an officer, reported a disposal of 152,561 Class A shares on 10/08/2025, reducing direct share ownership. At the same time, the officer retains sizeable equity compensation in the form of RSUs and a 50,000-share stock appreciation right with a $5.8 strike.
Governance implications center on alignment: staged vesting through 2028 preserves long-term incentives but the sizable contemporaneous sale may prompt investor questions about near-term liquidity needs versus confidence; monitor scheduled vesting through 2028 for future dilution and potential sales.
Equity grants are structured with multi-year vesting, including a recent large RSU award.
Newly reported awards include 121,792 RSUs granted at $0 per unit that vest annually in 2026–2028, alongside prior RSU tranches (83,334 and 76,820) and a 50,000-share SAR with staged vesting. These awards convert to Class A shares on vesting, increasing potential share count.
From a compensation-cost perspective, the schedule spreads dilution across 2026–2028. Investors should note the aggregate number of equity units that become deliverable each year as a measurable dilution vector over the next 3 years.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 121,792 | $0.00 | -- |
| holding | Stock Appreciation Right (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- Includes 83,334 shares of restricted stock that vest as follows: 41,666 vest on April 25, 2026 and 41,668 vest on April 25, 2027. Of such stock appreciation rights, 16,666 vested on May 16, 2024, 16,666 vested on May 1, 2025 and 16,668 vest on May 1, 2026. Each restricted stock unit has a value equal to one share of Class A common stock. Of such RSUs, 41,666 vest on April 25, 2026 and 41,668 vest on April 25, 2027. Each restricted stock unit has a value equal to one share of Class A common stock. Of such RSUs, 25,607 vest on May 1 of each of 2026 and 2027 and 25,606 vest on May 1, 2028. Each restricted stock unit has a value equal to one share of Class A common stock. Of such RSUs, 40,597 vest on October 8 of each of 2026 and 2027 and 40,598 vest on October 8, 2028.
